|
RNA | Avidity Biosciences, Inc. |
|
|
RNA | Avidity Biosciences, Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.65 |
| Leverage | 8.37% |
| Market Cap | $ 2.3B |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -278.2m |
| Margin | -2927.89% |
Avidity Biosciences, Inc., a biopharmaceutical company, is dedicated to the development of oligonucleotide-based therapies. The company is headquartered in La Jolla, California.